Profile
Oved Amitay formerly worked at The Solve ME, as President, Chief Executive Officer & Director from 2020 to 2023, CeNeS Pharmaceuticals, Inc., as Staff Pharmacologist, Genzyme Corp., as Vice President-Strategic Development from 1998 to 2011, Alnylam Pharmaceuticals, Inc., as Vice President & Head-Commercial from 2012 to 2016, Peptor Ltd, as Staff Pharmacologist, Arrett Neuroscience, Inc., as President & Chief Operating Officer from 2016 to 2018, and Centogene NV, as Chief Business Officer from 2018 to 2020.
Mr. Amitay received his graduate degree from Northeastern University and undergraduate degree from The Hebrew University of Jerusalem.
Former positions of Oved Amitay
| Companies | Position | End |
|---|---|---|
The Solve ME/CFS Initiative
 The Solve ME/CFS Initiative Miscellaneous Commercial ServicesCommercial Services The Solve ME/CFS Initiative is a non-profit organization that focuses on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), long COVID, and other post-infection diseases. The non-profit company is based in Glendale, CA. The organization provides answers and links to information for those living with and managing ME/CFS or long COVID. ME/CFS is a chronic, complex, neuroimmune disease that limits the health and productivity of patients and is often triggered by an infection. The organization's advocacy cafe chat series features community members sharing their stories to advocate for change. The Solve ME Research Advisory Council includes professionals from many fields that touch on ME/CFS. The company was founded in 1987. Oved Amitay has been the CEO of the company since 2020. | Chief Executive Officer | 2023-10-15 |
| CENTOGENE N.V. | Corporate Officer/Principal | 2020-05-30 |
| Arrett Neuroscience, Inc. | President | 2017-12-31 |
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2016-05-31 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2010-12-31 |
Training of Oved Amitay
| Northeastern University | Graduate Degree |
| The Hebrew University of Jerusalem | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| CENTOGENE N.V. | Commercial Services |
| Private companies | 5 |
|---|---|
CeNeS Pharmaceuticals, Inc.
 CeNeS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CeNeS Pharmaceuticals, Inc. discovers and develops proprietary pharmaceuticals to prevent and treat disorders and injuries of the nervous system. The company is headquartered in Cambridge, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
| Peptor Ltd | Health Technology |
The Solve ME/CFS Initiative
The Solve ME/CFS Initiative Miscellaneous Commercial ServicesCommercial Services The Solve ME/CFS Initiative is a non-profit organization that focuses on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), long COVID, and other post-infection diseases. The non-profit company is based in Glendale, CA. The organization provides answers and links to information for those living with and managing ME/CFS or long COVID. ME/CFS is a chronic, complex, neuroimmune disease that limits the health and productivity of patients and is often triggered by an infection. The organization's advocacy cafe chat series features community members sharing their stories to advocate for change. The Solve ME Research Advisory Council includes professionals from many fields that touch on ME/CFS. The company was founded in 1987. Oved Amitay has been the CEO of the company since 2020. | Commercial Services |
| Arrett Neuroscience, Inc. |
- Stock Market
- Insiders
- Oved Amitay
